These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26893382)
21. Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus. Lee T; Tanaka H; Ohira M; Kubo N; Sakurai K; Toyokawa T; Muguruma K; Yamashitaz Y; Maeda K; Hirakawa K Hepatogastroenterology; 2014; 61(133):1235-40. PubMed ID: 25436289 [TBL] [Abstract][Full Text] [Related]
22. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis. Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686 [TBL] [Abstract][Full Text] [Related]
23. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery. Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308 [TBL] [Abstract][Full Text] [Related]
24. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100 [TBL] [Abstract][Full Text] [Related]
25. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma. Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy. Wu SG; Li FY; Zhou J; Lin Q; Sun JY; Lin HX; Guan XX; He ZY Ann Thorac Surg; 2015 Jan; 99(1):284-90. PubMed ID: 25440270 [TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749 [TBL] [Abstract][Full Text] [Related]
28. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery. Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879 [TBL] [Abstract][Full Text] [Related]
29. Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma. Ma Q; Liu W; Long H; Rong T; Zhang L; Lin Y; Ma G J Cardiothorac Surg; 2015 Sep; 10():123. PubMed ID: 26384482 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610 [TBL] [Abstract][Full Text] [Related]
31. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study. Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907 [TBL] [Abstract][Full Text] [Related]
32. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer. Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732 [TBL] [Abstract][Full Text] [Related]
33. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170 [TBL] [Abstract][Full Text] [Related]
34. Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Miyata H; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y Ann Surg; 2015 Aug; 262(2):280-5. PubMed ID: 25211269 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y J Surg Oncol; 2015 Jul; 112(1):60-5. PubMed ID: 26179950 [TBL] [Abstract][Full Text] [Related]
36. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands. Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691 [TBL] [Abstract][Full Text] [Related]
37. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer. Sun ZG; Wang Z Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618 [TBL] [Abstract][Full Text] [Related]
38. [Prognostic value of three different staging schemes based on pN, MLR and LODDS in patients with T3 esophageal cancer]. Wang L; Cai L; Chen Q; Jiang YH Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):749-753. PubMed ID: 29061018 [No Abstract] [Full Text] [Related]
39. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy. Zhang H; Liang H; Gao Y; Shang X; Gong L; Ma Z; Sun K; Tang P; Yu Z Sci Rep; 2016 Dec; 6():38804. PubMed ID: 27941828 [TBL] [Abstract][Full Text] [Related]
40. Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis. Hsu HY; Chao YK; Hsieh CH; Wen YW; Chang HK; Tseng CK; Liu YH Ann Thorac Surg; 2016 Nov; 102(5):1687-1693. PubMed ID: 27457831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]